Due to a production error, an incorrect number was provided for “the National Natural Science Foundation of China”. The correct number is 82274194.
The publisher apologizes for this mistake. The original version of this article has been updated.
. 2024 Dec 9;15:1534991. doi: 10.3389/fphar.2024.1534991
Erratum: Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism
Frontiers Production Office1,*
1
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Received 2024 Nov 26; Accepted 2024 Nov 26; Collection date 2024.
Keywords: glutathione, acute hepatic encephalopathy, oxidative stress, endoplasmic reticulum stress, iNOS/ATF4/Ddit3
Copyright © 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC11663629 PMID: 39717559
This corrects the article "Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism", 1387409.